Outcomes and costs of positron emission tomography: Comparison of intravenous adenosine and intravenous dipyridamole

Clinical Therapeutics

Volumn 19, Issue 3, 1997, Pages 570-581

  Holmberg, M Jeffrey ^a   Mohiuddin, Syed M ^a   Hilleman, Daniel E ^a,d   Lucas Jr , B Daniel ^b   Wadibia, E Chuma ^c  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

^c AUBURN UNIVERSITY   (United States)

^d CREIGHTON UNIVERSITY SCHOOL OF PHARMACY AND HEALTH PROFESSIONS   (United States)

Author keywords

Adenosine; Cost effectiveness; Dipyridamole; Positron emission tomography

Indexed keywords

ADENOSINE; DIPYRIDAMOLE; NITROGEN 13;

ADULT; ADVERSE DRUG REACTION; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; COST; COST EFFECTIVENESS ANALYSIS; DRUG COST; FEMALE; FOLLOW UP; HEART CATHETERIZATION; HEART RATE; HOSPITAL COST; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; POSITRON EMISSION TOMOGRAPHY; RETROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; UNIVERSITY HOSPITAL; VASODILATATION;

EID: 0030763658     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(97)80141-5     Document Type: Article

References (22)

1. Rossen JD, Simonetti I, Marcus ML, Winniford MD. Coronary dilation with standard dose dipyridamole and dipyridamole combined with handgrip. Circulation. 1989;79:566-572.
2. Bolognese L, Sarasso G, Bonho A, et al. Dipyridamole echocardiography test: A new tool for detecting jeopardized myocardium after thrombolytic therapy. Circulation. 1991;84:1100-1106.
3. Biagini A, Maffei S, Baroni M, et al. Role of dipyridamole echocardiography test on the evaluation of coronary reserve after coronary artery bypass grafting. J Thorac Cardiovasc Surg. 1991;101:116-120.
4. Brown BG, Josephon MA, Petersen RB, et al. Intravenous dipyridamole combined with isometric handgrip for near maximal acute increase in coronary flow in patients with coronary artery disease. Am J Cardiol. 1981;48:1077-1085.
5. Casale PN, Guiney TE, Strauss AW, Bourcher CA. Simultaneous low level treadmill exercise and intravenous dipyridamole stress thallium imaging. Am J Cardiol. 1988;62:799-802.
6. Lam JYT, Chaitman BR, Glaenzer M. Safety and diagnostic accuracy of dipyridamole-thallium imaging in the elderly. J Am Coll Cardiol. 1988;11:585-589.
7. Wilson RF, Wyche K, Christensen BV, et al. Effects of adenosine on human coronary arterial circulation. Circulation. 1990;82:1595-1606.
8. Klabunde RD. Dipyridamole inhibition of adenosine metabolism in human blood. Eur J Pharmacol. 1983;93:21-26.
9. Gupta NC, Esterbrooks DJ, Mohiuddin SM, et al. Adenosine in myocardial perfusion imaging using position emission tomography. Am Heart J. 1991;122: 293-301.
10. Adenoscan® (adenosine). Prescription product information. Fujisawa USA, Inc, Deerfield, Illinois, 1996.
11. I.V. Persantine® (dipyridamole). Prescription product information. DuPont Pharma, Billerica, Massachusetts, April 1995.
12. National Center for Health Statistics. Vital Statistics of the United States, 1986. Vol. II. Mortality. Part A. DHHS Pub. No. (PHS) 89-1101. Washington, DC: US Public Health Service; 1989.
13. Belardinelli L, Linden J, Berne R. The cardiac effects of adenosine. Prog Cardiovasc Dis. 1989;32:73-97.
14. Moser GH, Schroder J, Deussen A. Turnover of adenosine in plasma of human and dog blood. Am J Physiol. 1989; 256:C799-C806.
15. Iskandrian AS, Heo J, Askenase A, et al. Dipyridamole cardiac imaging. Am Heart J. 1988;115:432-443.
16. Picano E. Dipyridamole-echocardiography test: Historical background and physiologic basis. Eur Heart J. 1989;10: 365-476.
17. Hanley FL, Grattan MT, Stevens MB, et al. Role of adenosine in coronary autoregulation. Am J Physiol. 1986;250: H558-H566.
18. Kurtz A. Adenosine stimulates guanylate cyclase activity in vascular smooth muscles. J Biol Chem. 1987;262:6296-6300.
19. Sewster CS, Olin BR, Hebel SK, et al, eds. Drug Facts and Comparisons. St. Louis, Mo: Facts and Comparisons, Inc; 1991:85a, 750b.
20. Ranhosky A, Kempthorne-Rawson J. The safety of intravenous dipyridamole thallium myocardial perfusion imaging. Circulation. 1990;81:23,384-23,389.
21. Cerqueria M, Verani MS, Schwaiger M, et al. Safety profile of adenosine stress perfusion imaging in 9,256 patients. Results from the Adenoscan Multicenter Trial Registry. J Am Coll Cardiol. 1994;23: 384-389.
22. Taillefer R, Amyot R, Turpin S, et al. Comparison between dipyridamole and adenosine in detection of coronary artery disease with T1-201 imaging. J Nucl Med. 1996;3:204-211.